missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18470403

CD63 Antibody (AD1), mFluor Violet 500 SE, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-68077MFV500

Product Code. 18470403

  • 583.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD63 Monoclonal antibody specifically detects CD63 in Rat samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD63
Monoclonal
mFluor Violet 500 SE
50mM Sodium Borate
Mouse
Affinity purified
RUO
Primary
Rat
Purified
Flow Cytometry
AD1
Flow Cytometry
CD_antigen: CD63, CD63, CD63 antigen, CD63 antigen (melanoma 1 antigen), CD63 molecule, Granulophysin, LAMP-3, Lysosomal-associated membrane protein 3, lysosome-associated membrane glycoprotein 3, ME491, melanoma 1 antigen, Melanoma-associated antigen ME491, melanoma-associated antigen MLA1, MLA1, Ocular melanoma-associated antigen, OMA81H, Tetraspanin-30, tspan-30, Tspan30
RBL-2H3 rat basophilic leukemia cells.
0.1 mL
Autophagy, Cancer, Cardiovascular Biology, Cellular Signaling, Cytokine Research, Immunology, Innate Immunity, Lysosome Markers, Metastasis
967
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.